Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents
Twenty six new pyrazoline substituted benzenesulfonylurea derivatives (2a–z) were synthesized and characterized. Out of these fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were evaluated for their antiproliferative activity towards 60 human cancer cell lines. Twenty six new pyrazoline substituted benz...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 24; no. 7; pp. 1685 - 1691 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
01.04.2014
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Twenty six new pyrazoline substituted benzenesulfonylurea derivatives (2a–z) were synthesized and characterized. Out of these fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were evaluated for their antiproliferative activity towards 60 human cancer cell lines.
Twenty six new pyrazoline substituted benzenesulfonylureas (2a–z) were synthesized and tested for in vitro anticancer activity. Fourteen derivatives (2i, 2k–2p, 2r, 2s–2x) were screened for their antiproliferative activity towards 60 human cancer cell lines by the National Cancer Institute (USA). Among them four compounds (2i, 2n, 2v and 2x) exhibited significant growth inhibition and further screened at 10-fold dilutions of five different concentrations (0.01, 0.1, 1, 10 and 100μM). The compounds 2i, 2n, 2v and 2x showed effective growth inhibition (GI50 MID) values of 2.62, 3.93, 3.33, 3.74μM respectively beside cytostatic activity TGI (MG-MID) values of 8.42, 65.80, 24.00 and 36.06μM respectively. The compound 2i displayed remarkable antiproliferative activity in 8 different cell lines with GI50 less than 2μM. Compounds 2n, 2v and 2x also displayed good antiproliferative activity against 11, 18 and 14 different cell lines respectively with GI50 less than 3μM. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2014.02.059 |